Navigation Links
Breakthrough in micro-device fabrication combines biology and synthetic chemistry

Nanostructured micro-devices may be mass produced at a lower cost, and with a wider variety of shapes and compositions than ever before, for dramatic improvements in device performance by utilizing very small biologically produced structures. These entirely new biologically-enabled approaches are detailed in the current issue of the International Journal of Applied Ceramic Technology, published on behalf of The American Ceramic Society.

This study's newly invented approaches for the low-cost mass production of micro-devices could yield unprecedented breakthroughs in genetically engineered microdevices (GEMs) for biomedical, computing, environmental cleanup, defense and numerous other applications.

Conventional microfabrication processes, similar to methods used to make computer microchips, are expensive (i.e., capital equipment intensive) and not well-suited for directly producing large numbers of complex, three-dimensional, nanostructured devices with a wide variety of chemistries and properties. Nature, on the other hand, provides spectacular examples of micro-organisms that synthesize microscopic nanostructured shells with well-controlled and highly-reproducible 3-D shapes and features currently unattainable by manmade processes. However, the naturally occurring diatom microshells do not have the specific properties needed for device applications, such as electrical conductivity, biocompatibility, thermal stability, and chemical compatibility.

According to the study's lead author, Kenneth Sandhage, "By demonstrating that biologically derived structures can be chemically modified without changing the starting shapes or fine features, we have opened the door for new research and development in the processing and application of many devices that would otherwise be very difficult or expensive to produce."


'"/>

Source:Blackwell Publishing Ltd.


Page: 1

Related biology news :

1. Breakthrough Microarray-based Technology for the Study of Cancer
2. Leukemia Drug Breakthrough Study In New England Journal Of Medicine
3. Breakthrough method in nanoparticle synthesis paves the way for new pharmaceutical and biomedical applications
4. Breakthrough isolating embryo-quality stem cells from blood
5. Breakthrough System for Understanding Ocean Plant Life Announced
6. Breakthrough: Scientists create worlds tiniest organic particles
7. Sciences Breakthrough of the Year: Watching evolution in action
8. Breakthrough for stem cell research
9. Breakthrough in understanding type-2 diabetes as key genes identified
10. Breakthrough vaccine to treat chemo-resistant ovarian cancer
11. Molecular biology fills gaps in knowledge of bat evolution
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/18/2017)... 18, 2017  In vitro diagnostic (IVD) companies were ... acquisitions (M&A), and Kalorama Information expects that trend to ... been shifting. Generally, uncertainty in reimbursement and healthcare reform ... has changed the acquisitions landscape. Instead of looking to ... buying partners outside of their home country and also ...
(Date:1/12/2017)... , Jan. 12, 2017  Trovagene, Inc. (NASDAQ: ... DNA (ctDNA) technologies, today announced that it has signed ... and the Middle East ...  This milestone marks the first wave of international distribution ... urine and blood samples. The initial partners ...
(Date:1/11/2017)... DES MOINES, Iowa , Jan. 11, 2017 /PRNewswire/ ... another industry first with the release of its patent-pending ... to quickly and reliably perform calibrations, securely upload data ... more flexibility for the customer. "Fighting drunk ... not only for the public at large, but also ...
Breaking Biology News(10 mins):
(Date:1/23/2017)... CARLOS, Calif. , Jan. 23, 2017 /PRNewswire/ ... developing innovative treatments for neurodegenerative diseases and other ... has joined the company as Chief Medical Officer. ... translational and clinical development activities at Alkahest and ... Dr. Jackson most recently served as Executive Director ...
(Date:1/21/2017)... ... 20, 2017 , ... G&L Scientific Inc, a leading provider ... ), has announced the opening of new offices in Cambridge, Massachusetts, strengthening and ... This is the latest step in G&L’s expansion of its global clinical consulting ...
(Date:1/21/2017)... 2017 Interpace Diagnostics Group, Inc. (NASDAQ: ... clinically useful molecular diagnostic tests and pathology services, ... securities purchase agreement with three  institutional investors to ... stock in a registered direct offering.  In a ... sell to the same investors warrants to purchase ...
(Date:1/21/2017)... Jan. 21, 2017   Boston Biomedical , an ... to target cancer stemness pathways, today presented data from ... at the 2017 American Society of Clinical Oncology (ASCO) ... . In a Phase Ib/II study ... to inhibit cancer stemness pathways by targeting STAT3 – ...
Breaking Biology Technology: